• 2022
  Bretagne S, Sitbon K, Desnos-Ollivier M, Garcia-Hermoso D, Letscher-Bru V, Cassaing S, Millon L, Morio F, Gangneux JP, Hasseine L, Favennec L, Cateau E, Bailly E, Moniot M, Bonhomme J, Desbois-Nogard N, Chouaki T, Paugam A, Bouteille B, Pihet M, Dalle F, Eloy O, Sasso M, Demar M, Mariani-Kurkdjian P, Robert V, Lortholary O, Dromer F, , , Active Surveillance Program to Increase Awareness on Invasive Fungal Diseases: the French RESSIF Network (2012 to 2018)., mBio 2022 Jun; 13(3): e0092022.
• 2021
  Bretagne S, Sitbon K, Botterel F, Dellière S, Letscher-Bru V, Chouaki T, Bellanger AP, Bonnal C, Fekkar A, Persat F, Costa D, Bourgeois N, Dalle F, Lussac-Sorton F, Paugam A, Cassaing S, Hasseine L, Huguenin A, Guennouni N, Mazars E, Le Gal S, Sasso M, Brun S, Cadot L, Cassagne C, Cateau E, Gangneux JP, Moniot M, Roux AL, Tournus C, Desbois-Nogard N, Le Coustumier A, Moquet O, Alanio A, Dromer F, , , COVID-19-Associated Pulmonary Aspergillosis, Fungemia, and Pneumocystosis in the Intensive Care Unit: a Retrospective Multicenter Observational Cohort during the First French Pandemic Wave., Microbiol Spectr 2021 Oct; (): e0113821.
• 2021
  Bretagne S, Desnos-Ollivier M, Sitbon K, Lortholary O, Che D, Dromer F, , , No Impact of Fluconazole to Echinocandins Replacement as First-Line Therapy on the Epidemiology of Yeast Fungemia (Hospital-Driven Active Surveillance, 2004-2017, Paris, France)., Front Med (Lausanne) 2021 ; 8(): 641965.
• 2018
  Robin C, Cordonnier C, Sitbon K, Raus N, Lortholary O, Maury S, Peffault de la Tour R, Bretagne S, Bastuji-Garin S, , Mainly Post-Transplant Factors Are Associated with Invasive Aspergillosis after Allogeneic Stem Cell Transplantation: A Study from the Surveillance des Aspergilloses Invasives en France and Société Francophone de Greffe de Moelle et de Thérapie Cellulaire, Biol. Blood Marrow Transplant. 2019 Feb;25(2):354-361.
• 2017
  Bretagne S, Renaudat C, Desnos-Ollivier M, Sitbon K, Lortholary O, Dromer F, , , Predisposing factors and outcome of uncommon yeast species-related fungaemia based on an exhaustive surveillance programme (2002-14)., J Antimicrob Chemother 2017 Jun; 72(6): 1784-1793.
• 2017
  Lortholary O, Renaudat C, Sitbon K, Desnos-Ollivier M, Bretagne S, Dromer F, , , The risk and clinical outcome of candidemia depending on underlying malignancy., Intensive Care Med 2017 May; 43(5): 652-662.
• 2016
  Guégan S, Garcia-Hermoso D, Sitbon K, Ahmed S, Moguelet P, Dromer F, Lortholary O,, Ten-Year Experience of Cutaneous and/or Subcutaneous Infections Due to Coelomycetes in France, Open Forum Infect Dis 2016 Apr;3(2):ofw106.
• 2015
  Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O,, Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis, J. Antimicrob. Chemother. 2015 Nov;70(11):3116-23.
• 2015
  Bernardeschi C, Foulet F, Ingen-Housz-Oro S, Ortonne N, Sitbon K, Quereux G, Lortholary O, Chosidow O, Bretagne S,, Cutaneous Invasive Aspergillosis: Retrospective Multicenter Study of the French Invasive-Aspergillosis Registry and Literature Review, Medicine (Baltimore) 2015 Jul;94(26):e1018.
• 2015
  Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, , , Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation., mBio 2015 Jun; 6(3): e00311.
• 2013
  Bernard C, Maucort-Boulch D, Varron L, Charlier C, Sitbon K, Freymond N, Bouhour D, Hot A, Masquelet AC, Valeyre D, Costedoat-Chalumeau N, Etienne M, Gueit I, Jouneau S, Delaval P, Mouthon L, Pouget J, Serratrice J, Brion JP, Vaylet F, Bremont C, Chennebault JM, Jaffuel S, Broussolle C, Lortholary O, Sève P, , Cryptococcosis in sarcoidosis: cryptOsarc, a comparative study of 18 cases, QJM 2013 Jun;106(6):523-39.
• 2012
  Troke P, Obenga G, Gaujoux T, Goldschmidt P, Bienvenu AL, Cornet M, Grenouillet F, Pons D, Ranque S, Sitbon K, Chaumeil C, Borderie V, Lortholary O, The efficacy of voriconazole in 24 ocular Fusarium infections, Infection 2013 Feb;41(1):15-20.
• 2011
  Blanchard E, Lortholary O, Boukris-Sitbon K, Desnos-Ollivier M, Dromer F, Guillemot D, , , Prior caspofungin exposure in patients with hematological malignancies is a risk factor for subsequent fungemia due to decreased susceptibility in Candida spp.: a case-control study in Paris, France., Antimicrob Agents Chemother 2011 Nov; 55(11): 5358-61.
• 2011
  Lortholary O, Gangneux JP, Sitbon K, Lebeau B, de Monbrison F, Le Strat Y, Coignard B, Dromer F, Bretagne S,, Epidemiological trends in invasive aspergillosis in France: the SAIF network (2005-2007), Clin. Microbiol. Infect. 2011 Dec;17(12):1882-9.
• 2010
  Lortholary O, Obenga G, Biswas P, Caillot D, Chachaty E, Bienvenu AL, Cornet M, Greene J, Herbrecht R, Lacroix C, Grenouillet F, Raad I, Sitbon K, Troke P,, International retrospective analysis of 73 cases of invasive fusariosis treated with voriconazole, Antimicrob. Agents Chemother. 2010 Oct;54(10):4446-50.
• 2005
  Lortholary O, Fontanet A, Mémain N, Martin A, Sitbon K, Dromer F,, Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France, AIDS 2005 Jul;19(10):1043-9.
• 2005
  Lortholary O, Sitbon K, Dromer F,, Evidence for human immunodeficiency virus and Cryptococcus neoformans interactions in the pro-inflammatory and anti-inflammatory responses in blood during AIDS-associated cryptococcosis, Clin. Microbiol. Infect. 2005 Apr;11(4):296-300.